David Geffen
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Diagnosis and Treatment
Papers in
- Oncology 29
- Cancer Treatment and Pharmacology 6
- HER2/EGFR in Cancer Research 6
-
- Breast Cancer Treatment Studies 11
- Cancer Genomics and Diagnostics 5
- Co-authors
- Samuel Ariad (17 shared papers)Netta Sion‐Vardy (2 shared papers)L. Bodner (1 shared paper)Michael R. Nash (1 shared paper)Daniel Benharroch (6 shared papers)Michael Koretz (9 shared papers)Salomon M. Stemmer (6 shared papers)Bella Kaufman (4 shared papers)
- Journals
- Oncology (4 papers)npj Breast Cancer (4 papers)Journal of Clinical Oncology (3 papers)Cancer (2 papers)Annals of Oncology (2 papers)
- Partner nations
- IsraelUnited StatesTaiwan
In The Last Decade
David Geffen
61 papers receiving 843 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 296
- Oncology 396
- Pathology and Forensic Medicine 182
- Oral Surgery 64
- Orthopedics and Sports Medicine 57
Countries citing papers authored by David Geffen
This map shows the geographic impact of David Geffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Geffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Geffen more than expected).
Fields of papers citing papers by David Geffen
This network shows the impact of papers produced by David Geffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Geffen. The network helps show where David Geffen may publish in the future.
Co-authors
The 25 scholars most cited alongside David Geffen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 68 | |
| 2 | Metastatic tumors to the jaws: a report of eight new cases. | 2006 | 63 |
| 3 | 2011 | 59 | |
| 4 | 2007 | 54 | |
| 5 | 2003 | 49 | |
| 6 | 1983 | 45 | |
| 7 | 2018 | 36 | |
| 8 | 2013 | 34 | |
| 9 | 1995 | 30 | |
| 10 | 2014 | 26 | |
| 11 | 1993 | 23 | |
| 12 | 2019 | 23 | |
| 13 | 2006 | 22 | |
| 14 | 2013 | 22 | |
| 15 | Disseminated intravascular coagulation at presentation of advanced gastric cancer. | 2006 | 22 |
| 16 | 2019 | 20 | |
| 17 | 2011 | 17 | |
| 18 | 2014 | 15 | |
| 19 | New drugs for the treatment of cancer, 1990-2001. | 2002 | 15 |
| 20 | 1992 | 14 |
About David Geffen
David Geffen is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Genetics, having authored 65 papers that have together received 869 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), Lymphoma Diagnosis and Treatment (8 papers), Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (6 papers), Cancer Genomics and Diagnostics (5 papers), Bone health and osteoporosis research (4 papers), BRCA gene mutations in cancer (4 papers) and Estrogen and related hormone effects (4 papers). The work is most often cited by research in Cancer Research (296 citations), Oncology (396 citations), Pathology and Forensic Medicine (182 citations), Oral Surgery (64 citations) and Orthopedics and Sports Medicine (57 citations). David Geffen has collaborated with scholars based in Israel, United States and Taiwan. Frequent co-authors include Samuel Ariad, Netta Sion‐Vardy, L. Bodner, Michael R. Nash, Daniel Benharroch, Michael Koretz, Salomon M. Stemmer, Bella Kaufman, Marianne Amir and Georgeta Fried. Their work appears in journals such as Oncology, npj Breast Cancer, Journal of Clinical Oncology, Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.